A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy

Villanueva, C.;Awada, A.;Campone, M.;Machiels, Jean-Pascal;Pivot, X.;et.al.
(2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Location: Berlin(Germany) (20.September.2009)

Files

58666.pdf
  • Restricted Access
  • Adobe PDF
  • 630.26 KB
Request a copy

Details

Authors
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Villanueva, C., Awada, A., Campone, M., Machiels, J.-P., Besse, T., Magherini, E., Dubin, F., Semiond, D., & Pivot, X. (2009). A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy. EJC - Supplements, 7(2), 268. https://hdl.handle.net/2078.5/146927 (Original work published 2009)